Conferences

DIA Biosimilars USA 2022

Home/Conferences | Posted 18/03/2022

Collaborate for Progress at DIA’s Biosimilars Conference in Arlington, VA – 20–21 September 2022

Medicines for Europe 18th Biosimilar Medicines Conference 2022

Home/Conferences | Posted 15/07/2022

TRANSLATING THE PHARMACEUTICAL LEGISLATION  INTO ACCESS & AFFORDABILITY
6‒7 October 2022
Thon Hotel EU Brussels
Belgium

IGBA Global Biosimilars Week 2022

Home/Conferences | Posted 20/01/2017

Global Biosimilars Week 2022
14-18 November 2022 | Third Annual

AAM GRx+Biosims 2022

Home/Conferences | Posted 01/04/2022

GRx+Biosims 2022
7−9 November 2022
Bethesda North Marriott Hotel and Conference Center
North Bethesda, Maryland, USA

2nd ASBM/GaBI biosimilar webinar on non-medical switching

Home/Conferences | Posted 03/06/2022

ASBM/GaBI Biosimilar Webinar Series 2022
NON-MEDICAL SWITCHING OF BIOLOGICALS/BIOSIMILARS: CANADA, EUROPE AND THE US
Overview of Non-Medical Switching Practices in Different Regions and the Importance of Safeguarding the Physician–Patient Relationship

20 July 2022 | WATCH REPLAY

Microbiological control symposium: consensus on readiness of new methods emerges

Home/Conferences | Posted 27/10/2017

A symposium on microbiology in the pharmaceutical sector was the opportunity for the European Directorate for the Quality of Medicines & HealthCare (EDQM) to gather feedback from users of the European Pharmacopoeia on alternative testing methods for microbiological control and sterilisation processes. The event, which took place in Strasbourg on 10−11 October 2017, was attended by a wide range of experts in the pharmaceutical and microbiological fields who reviewed the latest trends and innovations in the field of microbiology, in addition to pharmacopoeial approaches and related regulatory requirements.

European Pharmacopoeia prepares for the future through exchange with stakeholders

Home/Conferences | Posted 14/10/2016

To mark the publication of the 9th edition of the European Pharmacopoeia (Ph. Eur.), the EDQM (European Directorate for the Quality of Medicines) organized a large international conference in Tallinn, Estonia, which brought together representatives of European and international regulatory authorities, the World Health Organization (WHO), pharmacopoeias from different continents as well as industry and associations from Europe and beyond. Participants came from 41 different countries, including Brazil, Canada, India, Japan, South Africa, Taiwan and USA.

Extrapolation key issue at European biosimilars conference

Home/Conferences | Posted 25/09/2015

The European Generic medicines Association (EGA) held its 13th EGA-European Biosimilars Group Conference in London on 23–24 April 2015.

French generics association promotes biosimilars

Home/Conferences | Posted 17/10/2014

French generics association GEMME held its first symposium on the challenges and opportunities associated with biosimilars in France on 3 October 2014.

Topics presented at the 16th IGPA conference on generics

Home/Conferences | Posted 17/01/2014

Topics presented at the 16th Annual IGPA Conference, held in Brussels, Belgium, 9–11 December 2013, showed that despite differences in the pharmaceutical market in different countries most appreciate the value of generics. In most cases this is driven by cost reduction.